Osel and partners launch Phase IIb FLIP-2 trial of Lactin-V 

​Osel, together with Imperial College London’s Clinical Trials Unit and March of Dimes, has launched the Phase IIb FLIP-2 trial, assessing the efficacy and safety of Lactin-V, a microbiome-based therapy, in pregnant women at high risk of PTB.

The post Osel and partners launch Phase IIb FLIP-2 trial of Lactin-V  appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

Revvity secures FDA clearance for total testosterone immunoassay
Pfizer receives EC approval for Hympavzi to treat haemophilia
Roche’s Elecsys pTau217 blood test secures CE mark for Alzheimer’s
Alkermes reports encouraging data from Phase III study of Lumryz
Isomorphic Labs receives $2.1bn for AI drug development

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us